1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Jones Ventures INTL Acquisition1 Corp, a blank-check company with no target selected, closed its initial public offering of 20,000,000 units at $10.00 per unit on July 15, 2026, for gross proceeds of $200 million. The $200 million was placed in a U.S. trust account, and the company has 21 months from the closing to complete a business combination or return the trust funds to public shareholders.
Initial public offering of 20,000,000 units at $10.00 per unit, generating $200 million in gross proceeds on July 15, 2026
Private placement of 645,000 units to the sponsor and underwriter for $6,450,000
$200 million placed in a trust account at Citibank, N.A., with Equiniti Trust Company, LLC as trustee; underwriters have a 45-day option to buy up to 3,000,000 more units
Company had cash of $1,614,681 as of July 15, 2026, and must complete a business combination within 21 months
China Pharma Holdings agreed on July 22, 2026 to sell 2,500,000 shares of common stock at $2.00 per share, for gross proceeds of $5 million before fees and expenses, with closing expected around July 23, 2026. The company said it intends to use the net proceeds for working capital and general corporate purposes, but the sale adds new shares and includes investor participation rights and restrictions on future financings that shareholders should weigh.
Offering: 2,500,000 shares at $2.00 per share, for gross proceeds of $5 million
Placement agent FT Global Capital, Inc. receives a cash fee of 7.0% of aggregate proceeds
Investor may participate in up to 40% of subsequent financings for three months after closing
Company agreed not to enter new subsequent placements or Variable Rate Transactions until the 91st day after closing
Netflix completed a registered public offering of $1 billion in 5.250% senior unsecured notes due 2036 on July 22, 2026. The company plans to use the net proceeds to repay its 4.375% Senior Notes due 2026 at maturity and for general corporate purposes.
Offering size: $1 billion in principal amount of 5.250% senior unsecured notes due 2036
Proceeds to repay outstanding 4.375% Senior Notes due 2026 at maturity, plus general corporate purposes
Sold under shelf registration on Form S-3ASR (File No. 333-281071); underwriters include BNP Paribas Securities Corp. and Morgan Stanley & Co. LLC
On July 22, 2026, DarioHealth agreed to sell 2,437,060 common shares and pre-funded warrants for 1,017,499 shares to institutional investors in a registered direct offering priced at-the-market under Nasdaq rules, for gross proceeds of about $23.5 million before fees. The sale adds new shares outstanding, and the company has agreed not to issue more shares for 30 days after closing, which is expected on or about July 23, 2026, apart from its existing at-the-market facility.
Shares priced at $6.80 each; pre-funded warrants priced at $6.7999 each, covering 1,017,499 shares
Gross proceeds of about $23.5 million; placement agent cash fee of 6.0%, with a 1.0% fee on certain investor proceeds, plus expenses up to $60,000
Board member Dennis Matheis agreed to buy 14,430 shares at $6.93 per share
Company may not issue further shares for 30 days after closing, expected on or about July 23, 2026, except under its existing at-the-market facility and Form S-8 plans
STAG Industrial and its operating partnership entered into an amended term loan agreement dated July 16, 2026, combining its $150 million Unsecured Term Loan A and $200 million Unsecured Term Loan F into one $350 million senior unsecured loan. The new loan matures January 16, 2032, and its spread is reduced by five basis points. The company also amended its $1.0 billion unsecured credit facility and three term loans to cut their spreads by five basis points, with the filing stating the other terms are unchanged.
Unsecured Term Loan A ($150 million, due March 15, 2027) and Unsecured Term Loan F ($200 million, due March 25, 2029, assuming extensions) were combined into one $350 million loan maturing January 16, 2032.
The spread on the combined loan and on the $1.0 billion unsecured credit facility and Unsecured Term Loans G, H and I was reduced by five basis points, with the spread still tied to debt rating and leverage ratio.
As of July 20, 2026, $150 million was swapped to 2.01% until March 15, 2027, then 4.79% until January 16, 2032; $200 million was swapped to 4.68% until March 25, 2027, then 4.79% until January 16, 2032.
The amendments were signed on July 16, 2026, with Wells Fargo Bank, National Association, and other lenders.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.